ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORSMESM..................*JJDIM360 Ver 1.28 (29 Oct 2014) - 2999001/02533783CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120151216W173deBibliographieenBibliographyfrBibliographieEP11733353.4201101132012080720140520enenen294575 P20100113US2015121620155120121219201251201511042015452015092820151216201551A61K 31/497 20060101AFI20130611BHEP C07D 413/12 20060101ALI20130611BHEP C07D 417/14 20060101ALI20130611BHEP C07D 271/06 20060101ALI20130611BHEP C07D 413/14 20060101ALI20130611BHEP A61P 37/00 20060101ALI20130611BHEP deVERBINDUNGEN UND VERFAHREN zur Inhibierung von HDACenCOMPOUNDS AND METHODS for the inhibition of HDACfrCOMPOSÉS ET PROCÉDÉS pour l' inhibition d' HDACWO-A1-01/18045US-A1- 2009 048 22820130617BALOGLU, Erkan200 Technology SquareCambridge, MA 02139USGHOSH, Shomir200 Technology SquareCambridge, MA 02139USLOBERA, Mercedes200 Technology SquareCambridge, MA 02139USSCHMIDT, Darby200 Technology SquareCambridge, MA 02139USTempero Pharmaceuticals, Inc.101556501REP/PU64083CSC 2711 Centerville Road, Suite 400Wilmington, DE 19808USPriestley, Ruth Elizabethet al100039391GlaxoSmithKline Global Patents (CN925.1) 980 Great West RoadBrentford, Middlesex TW8 9GSGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRBA20120807ME20120807US201102108920110113enWO20110881812011072120112920121219201251